Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

43.68
+0.33100.76%
Post-market: 43.730.0498+0.11%19:30 EDT
Volume:24.00K
Turnover:1.04M
Market Cap:211.41M
PE:- -
High:43.73
Open:43.54
Low:43.28
Close:43.35
52wk High:47.00
52wk Low:26.52
Shares:4.84M
Float Shares:4.84M
Volume Ratio:1.14
T/O Rate:0.50%
Dividend:0.02
Dividend Rate:0.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Bristol Gate’s Richard Hamm Trims Eli Lilly Stake

TIPRANKS
·
Aug 15

Mirova US LLC trims Eli Lilly position by 14,395 shares

TIPRANKS
·
Aug 15

PRIMECAP Management Co trims Eli Lilly stake by 50K

TIPRANKS
·
Aug 15

Insulet Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 15

Eli Lilly & Co. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 15

Eli Lilly’s New Phase 1 Study Signals Ongoing Pipeline Expansion

TIPRANKS
·
Aug 15

Lilly Expands Obesity Pipeline With Fresh Macupatide Trial in Japan

TIPRANKS
·
Aug 15

China Merchants Adjusts Eli Lilly Price Target to $1,252 From $964, Maintains Buy Rating

MT Newswires Live
·
Aug 14

UBS Pursues Dual Strategy in Q2: Betting on AI Compute Boom While Hedging Crowded Trade Risks

Stock News
·
Aug 14

Eli Lilly & Co (LLY) Gets a Buy from Barclays

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Sands Capital boosts Eli Lilly stake with 12,445 shares

TIPRANKS
·
Aug 14

'It Feels Like a Medical Miracle': How Did a Single QR Code Coupon Cut My $618 Walgreens Prescription to $15?

Dow Jones
·
Aug 14

Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased

Reuters
·
Aug 14

Aktis Oncology Q2 FY26 Net Loss Widens 33.15% to $24.1 Million

Reuters
·
Aug 14

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

TIPRANKS
·
Aug 13

CorMedix Beats Q2 Revenue Estimates on DefenCath Growth, Raises FY Adjusted Ebitda Guidance

Reuters
·
Aug 13

Novo CEO Says Obesity Market Won't be Winner-Take-All Battle with Lilly

Reuters
·
Aug 13

Cullinan Climbs as Lung Cancer Drug Meets Late-Stage Trial Goal

Reuters
·
Aug 13

Berenberg Adjusts Price Target on Eli Lilly to $1,220 From $1,135, Maintains Hold Rating

MT Newswires Live
·
Aug 13